| Xenazine |
|
|
|
| Thursday, 05 April 2007 | |
|
Client: Huntsworth Health Tardive Dyskinesia is an iatrogenic movement disorder characterized by repetitive, involuntary movements. The resultant tics and tremors are often referred to as dyskinesias and include grimacing, tongue protrusion, and rapid eye blinking, rapid movements of the arms, legs and torso. The cause of Tardive Dyskinesia is related to damage of the system that uses and processes the neurotransmitter dopamine. As a result of the use of neuroleptic drugs, postsynaptic dopaminergic receptors become supersensitive to stimulation and this supersensitivity causes the symptoms. These neuroleptic drugs are usually prescribed for psychiatric disorders but drugs for gastrointestinal disorders and neurological disorders and even SSRI antidepressants, which are not intended to affect dopamine, may also cause Tardive Dyskinesia.Xenazine from Cambridge Laboratories is primarily proven to be effective in the treatment of the chorea associated with Huntington’s Disease, a hereditary and degenerative condition of the central nervous system, but can also be used to control iatrogenic movement disorders such as Tardive Dyskinesia. By depleting the stores of neurotransmitters within the nerve cells in the brain, Xenazine alters the transmission of electric signals from the brain that control movement. Dysfunction created content for various multimedia presentations, featuring footage of sufferers, as well as interviews with patients and key opinion lieaders on the efficacy of Xenazine. |
| Next > |
|---|